Usted buscó: rituksimabas (Lituano - Inglés)

rituksimabas
rituximab

rituksimabas+mtx
24 (itt population)

mabthera rituksimabas
mabthera rituximab

rituksimabas (n=99)
bronchitis

2 tyrimas rituksimabas
study 2

rituksimabas 500 mg / 50 ml
rituximab 500 mg / 50 ml

placebas+mtx1 rituksimabas+mtx1
week 24 response:

mabthera 1 400 mg rituksimabas
mabthera 1400 mg rituximab

veiklioji medžiaga yra rituksimabas.
the active ingredient is rituximab.

veiklioji mabthera medziaga yra rituksimabas.
the active ingredient in mabthera is called rituximab.

placebas+mtx rituksimabas+mtx 2×1g
radiographic mean changes over

mabthera 100 mg koncentratas infuziniam tirpalui rituksimabas
mabthera 100 mg concentrate for solution for infusion rituximab

rituksimabas labai specifiškas b ląstelių cd20 antigenui.
rituximab has shown to be highly specific to the cd20 antigen on b cells.

atsakas pagal placebas+mtx rituksimabas+mtx acr
acr response placebo+mtx rituximab+mtx

veiklioji mabthera medžiaga rituksimabas yra monokloninis antikūnas.
the active substance in mabthera, rituximab, is a monoclonal antibody.

mabthera tarptautinis nepatentinis pavadinimas (inn) ­ rituksimabas
mabthera international nonproprietary name (inn):rituximab

mabthera 1 400 mg tirpalas poodinei injekcijai rituksimabas poodinis
mabthera 1400 mg solution for subcutaneous injection rituximab subcutaneous

buteliuke yra 500 mg rituksimabo (10 mg/ ml).
the vial contains 500 mg of rituximab